PAK1/2/3 (Ab-423/402/421) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-PAK1/2/3 (Ab-423/402/421) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | PAK1/2/3 (Ab-423/402/421) |
| Clone | polyclonal |
| Host Species | n/a |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | Western Blot (WB), Immunohistochemistry (IHC), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: PAK1/2/3 (Ab-423/402/421) antibody detects endogenous levels of total PAK1/2/3 protein. |
| Immunogen | Immunogen: The antiserum was produced against synthesized non-phosphopeptide derived from humanPAK1/2/3 around the phosphorylation site of threonine 423/402/421 (R-S-TP-M-V). |
| Other Names | [EC 2.7.11.1; Gamma-PAK; P21-activated kinase 2; PAK 2; PAK-2; PAK65; PAKI; S6/H4 kinase; kinase PAK2; p21-activated kinase 2; p21-activated protein kinase IBeta-PAK; CDC42/RAC effector kinase PAK-B; EC 2.7.1.; EC 2.7.11.1; OPHN3; Oligophrenin-3; P65-PAK; PAK 3; PAK-3; PAKB; STK4; Serine/threonine-protein kinase PAK 3; kinase PAK3; p21-activated kinase 3], [PAK1; PAK1; PAKalpha; PAK-1] |
| Gene, Accession # | [PAK1/2/3], Gene ID: 5058, NCBI: NP_001122092.1, UniProt: Q13153 |
| Catalog # | MBS855271 |
| Price | $280 |
| Order / More Info | PAK1/2/3 (Ab-423/402/421) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Bernadett Boda, J. Neurosci., Dec 2004; 24: 10816-10825. Donna L. McPhie, J. Neurosci., Jul 2003; 23: 6914. Jin-Hun Jung, J. Biol. Chem., Dec 2005; 280: 40025-40031. Guo-Lei Zhou, Mol. Cell. Biol., Nov 2003; 23: 8058-8069. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies